Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Breast Cancer
-
-
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
-
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
-
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
-
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
-
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
-
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
-
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
-
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
-
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Categories
Alliance Committee
Browse by Year